Latest filing published 18 Feb 2021 for Organogenesis Holdings Inc..
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Wayne D. Mackie discloses dealings in 2 companies, chiefly Organogenesis Holdings Inc. and EXA Corp. In total, 23 filings cover trades dated from 5 January 2016 to 16 February 2021.
Every open-market trade on record is a purchase: 17 purchases worth €903k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants and 2 option exercises.
In size, the median ticket on the buying side is €22k. 9 out of 17 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. After 9 purchases with a full 90-day history, the hit rate stands at 22% and the median 90-day move at -14.4%. This is a record of the past, not a forecast.
On 18 February 2021 came the latest disclosure, a share grant in Organogenesis Holdings Inc. The clock since the last published purchase (3 December 2020) now reads 2,150 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations